Insider · CIK 0001963878

Bellon Christine

Reports to the SEC for 1 company · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001963878

Forms 4 and 5

Insider transactions

37 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-04-01	BEAMBeam Therapeutics Inc.S Sale	Chief Legal Officer	SSale	−5,956 sh	$24.58	−$146K	109,711
2026-03-31	BEAMBeam Therapeutics Inc.A Award	Chief Legal Officer	AAward	+20K sh	—	—	115,667
2026-01-31	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)A Award	Chief Legal Officer	AAward	+40K sh	—	—	40,000
2026-01-22	BEAMBeam Therapeutics Inc.S Sale	Chief Legal Officer	SSale	−1,371 sh	$34.00	−$46.6K	95,667
2026-01-15	BEAMBeam Therapeutics Inc.S Sale	Chief Legal Officer	SSale	−16K sh	$34.72	−$554K	97,597
2026-01-15	BEAMBeam Therapeutics Inc.S Sale	Chief Legal Officer	SSale	−2,111 sh	$33.62	−$71K	113,556
2026-01-15	BEAMBeam Therapeutics Inc.S Sale	Chief Legal Officer	SSale	−559 sh	$35.40	−$19.8K	97,038
2025-12-31	BEAMBeam Therapeutics Inc.S Sale	Chief Legal Officer	SSale	−1,254 sh	$27.10	−$34K	115,667
2025-10-01	BEAMBeam Therapeutics Inc.S Sale	Chief Legal Officer	SSale	−373 sh	$24.53	−$9,149.69	116,921
2025-04-01	BEAMBeam Therapeutics Inc.S Sale	Chief Legal Officer	SSale	−5,674 sh	$18.35	−$104K	117,294
2025-03-31	BEAMBeam Therapeutics Inc.A Award	Chief Legal Officer	AAward	+20K sh	—	—	122,968
2025-02-14	BEAMBeam Therapeutics Inc.M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+9,492 sh	$7.22	+$68.5K	112,460
2025-02-14	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−508 sh	—	—	10,410
2025-02-14	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−9,492 sh	—	—	0
2025-02-14	BEAMBeam Therapeutics Inc.S Sale	Chief Legal Officer	SSale	−10K sh	$34.00	−$340K	102,968
2025-02-14	BEAMBeam Therapeutics Inc.M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+508 sh	$7.22	+$3,667.76	112,968
2025-01-31	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)A Award	Chief Legal Officer	AAward	+40K sh	—	—	40,000
2025-01-02	BEAMBeam Therapeutics Inc.S Sale	Chief Legal Officer	SSale	−1,241 sh	$24.68	−$30.6K	102,968
2024-10-01	BEAMBeam Therapeutics Inc.S Sale	Chief Legal Officer	SSale	−385 sh	$23.48	−$9,039.569	104,209
2024-04-01	BEAMBeam Therapeutics Inc.S Sale	Chief Legal Officer	SSale	−3,401 sh	$32.12	−$109K	104,594
2024-03-31	BEAMBeam Therapeutics Inc.A Award	Chief Legal Officer	AAward	+27.5K sh	—	—	107,995
2024-01-31	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)A Award	Chief Legal Officer	AAward	+55K sh	$24.40	+$1.34M	55,000
2024-01-03	BEAMBeam Therapeutics Inc.S Sale	Chief Legal Officer	SSale	−1,907 sh	$26.42	−$50.4K	80,495
2023-11-20	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−5,818 sh	—	—	10,918
2023-11-20	BEAMBeam Therapeutics Inc.M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+5,818 sh	$7.22	+$42K	92,402
2023-11-20	BEAMBeam Therapeutics Inc.M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+4,182 sh	$7.22	+$30.2K	86,584
2023-11-20	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−4,182 sh	—	—	9,492
2023-11-20	BEAMBeam Therapeutics Inc.S Sale	Chief Legal Officer	SSale	−5,000 sh	$31.00	−$155K	82,402
2023-11-20	BEAMBeam Therapeutics Inc.S Sale	Chief Legal Officer	SSale	−5,000 sh	$30.00	−$150K	87,402
2023-10-02	BEAMBeam Therapeutics Inc.S Sale	Chief Legal Officer	SSale	−388 sh	$22.85	−$8,865.8	82,402
2023-04-04	BEAMBeam Therapeutics Inc.S Sale	Chief Legal Officer	SSale	−1,161 sh	$29.09	−$33.8K	82,790
2023-04-03	BEAMBeam Therapeutics Inc.S Sale	Chief Legal Officer	SSale	−931 sh	$30.31	−$28.2K	83,951
2023-03-31	BEAMBeam Therapeutics Inc.A Award	Chief Legal Officer	AAward	+17.5K sh	—	—	84,882
2023-03-30	BEAMBeam Therapeutics Inc.M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+2,669 sh	$7.22	+$19.3K	67,382
2023-03-30	BEAMBeam Therapeutics Inc.M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+6,272 sh	$7.22	+$45.3K	64,713
2023-03-30	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−6,272 sh	—	—	13,674
2023-03-30	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−2,669 sh	—	—	16,736

Recent filings

Accepted (ET)
Apr 64
Bellon Christine0001193125-26-144067
SEC(opens sec.gov)
Apr 24
Bellon Christine0001193125-26-140586
SEC(opens sec.gov)
Feb 24
Bellon Christine0001193125-26-033601
SEC(opens sec.gov)
Jan 264
Bellon Christine0001193125-26-022557
SEC(opens sec.gov)
Jan 204
Bellon Christine0001193125-26-016552
SEC(opens sec.gov)
Jan 54
Bellon Christine0001193125-26-002427
SEC(opens sec.gov)
Oct 34
Bellon Christine0001193125-25-230148
SEC(opens sec.gov)
Apr 34
Bellon Christine0000950170-25-050859
SEC(opens sec.gov)
Apr 24
Bellon Christine0000950170-25-049769
SEC(opens sec.gov)
Feb 194
Bellon Christine0000950170-25-023166
SEC(opens sec.gov)
Feb 34
Bellon Christine0000950170-25-012307
SEC(opens sec.gov)
Jan 64
Bellon Christine0000950170-25-002358
SEC(opens sec.gov)
Oct 24
Bellon Christine0000950170-24-111739
SEC(opens sec.gov)
Apr 34
Bellon Christine0000950170-24-041438
SEC(opens sec.gov)

Companies

Beam Therapeutics Inc.Chief Legal OfficerBEAM

Address

C/O BEAM THERAPEUTICS INC., 238 MAIN STREET

CAMBRIDGE, MA, 02142